# Jungang Xie

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jungang-xie/

## Facts

| Field | Value |
| --- | --- |
| Citations | 57,918 |
| Field | Asthma and respiratory diseases |
| h-index | 32 |
| i10-index | 80 |
| Last Known Institution | Huazhong University of Science and Technology |
| OpenAlex ID | https://openalex.org/A5058709579 |
| ORCID iD | https://orcid.org/0000-0001-9037-3027 |
| Works | 147 |

## Researcher papers

- [Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial](https://scholariq.org/papers/ruxolitinib-in-treatment-of-severe-coronavirus-disease-2019-covid-19-a/)

## Researcher topics

- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)
- [Chronic Obstructive Pulmonary Disease (COPD) Research](https://scholariq.org/topics/chronic-obstructive-pulmonary-disease-copd-research/)
- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [IL-33, ST2, and ILC Pathways](https://scholariq.org/topics/il-33-st2-and-ilc-pathways/)
- [Long-Term Effects of COVID-19](https://scholariq.org/topics/long-term-effects-of-covid-19/)

## Researcher university

- [Huazhong University of Science and Technology](https://scholariq.org/institutions/huazhong-university-of-science-and-technology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
